Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer
The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1014731.htm
- Syndication ID: 19832
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:16 PM
- Date Syndication Updated: Wednesday, September 02, 2020 at 09:12 AM
Embed Code Snippet
To get the embed code snippet please Login.
